Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypogonadism | 2 | 2020 | 278 | 0.660 |
Why?
|
| Testosterone | 2 | 2020 | 638 | 0.500 |
Why?
|
| Receptors, Androgen | 3 | 2016 | 854 | 0.420 |
Why?
|
| Weight Loss | 3 | 2022 | 628 | 0.390 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2395 | 0.340 |
Why?
|
| Bone Density | 2 | 2024 | 467 | 0.330 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 762 | 0.300 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 1011 | 0.280 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1704 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 2050 | 0.240 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 26 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 1416 | 0.200 |
Why?
|
| Body Composition | 2 | 2024 | 602 | 0.190 |
Why?
|
| Androgen-Insensitivity Syndrome | 2 | 2011 | 34 | 0.180 |
Why?
|
| Obesity | 2 | 2024 | 2893 | 0.170 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 127 | 0.170 |
Why?
|
| Remote Consultation | 1 | 2018 | 35 | 0.160 |
Why?
|
| Reproduction | 1 | 2020 | 276 | 0.150 |
Why?
|
| Habenula | 1 | 2018 | 45 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2020 | 605 | 0.140 |
Why?
|
| Neural Pathways | 1 | 2018 | 311 | 0.130 |
Why?
|
| Genetic Variation | 2 | 2016 | 2157 | 0.130 |
Why?
|
| Estrogens | 1 | 2020 | 804 | 0.130 |
Why?
|
| Endocrinology | 1 | 2018 | 155 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2016 | 12036 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 5870 | 0.120 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2016 | 103 | 0.120 |
Why?
|
| Brain Mapping | 1 | 2018 | 624 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 454 | 0.110 |
Why?
|
| Biomarkers | 2 | 2024 | 5050 | 0.100 |
Why?
|
| Castration | 1 | 2012 | 122 | 0.100 |
Why?
|
| Chromones | 1 | 2012 | 121 | 0.100 |
Why?
|
| Precision Medicine | 2 | 2011 | 1216 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 162 | 0.100 |
Why?
|
| Androstadienes | 1 | 2012 | 172 | 0.100 |
Why?
|
| Quinazolines | 1 | 2016 | 956 | 0.090 |
Why?
|
| Morpholines | 1 | 2012 | 296 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 3328 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2012 | 843 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2009 | 204 | 0.080 |
Why?
|
| Male | 7 | 2024 | 128520 | 0.060 |
Why?
|
| Androgens | 2 | 2020 | 506 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2020 | 2855 | 0.050 |
Why?
|
| Humans | 10 | 2024 | 270804 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 14885 | 0.050 |
Why?
|
| Disease Progression | 1 | 2012 | 6881 | 0.050 |
Why?
|
| Phenotype | 1 | 2012 | 6503 | 0.050 |
Why?
|
| Mutation | 2 | 2011 | 15922 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2020 | 104 | 0.040 |
Why?
|
| Life Style | 1 | 2022 | 617 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 215 | 0.040 |
Why?
|
| Anthropometry | 1 | 2018 | 260 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 311 | 0.040 |
Why?
|
| Metabolome | 1 | 2020 | 355 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2011 | 1683 | 0.030 |
Why?
|
| Estradiol | 1 | 2020 | 828 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 418 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 370 | 0.030 |
Why?
|
| Connectome | 1 | 2018 | 114 | 0.030 |
Why?
|
| Quality of Life | 2 | 2022 | 4810 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 5053 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 509 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2018 | 664 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 2575 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 362 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 14639 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 825 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 925 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 1424 | 0.030 |
Why?
|
| Taxoids | 1 | 1996 | 1019 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1996 | 898 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 2393 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 617 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 15951 | 0.020 |
Why?
|
| Aged | 3 | 2022 | 73640 | 0.020 |
Why?
|
| Middle Aged | 3 | 2024 | 90569 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 3058 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1996 | 2114 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2009 | 233 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6193 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6234 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 651 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 738 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3930 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 1469 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 82073 | 0.020 |
Why?
|
| Algorithms | 1 | 1996 | 3908 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 15280 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 1715 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 1647 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 7233 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 7323 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 22533 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 7923 | 0.010 |
Why?
|
| United States | 1 | 2018 | 15834 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 9047 | 0.010 |
Why?
|
| Solutions | 1 | 1996 | 109 | 0.010 |
Why?
|
| Solvents | 1 | 1996 | 67 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1996 | 158 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 39982 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1996 | 527 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 606 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1996 | 1736 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 61362 | 0.010 |
Why?
|
| Female | 1 | 2018 | 148936 | 0.000 |
Why?
|